Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Collegium Pharmaceutical Inc. (COLL)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2024 Q2 | 39,596 | 0.02 | Add 346.25% | 0.02 | $32.20 | $1,274,991 | SEC |
| 2024 Q1 | 8,873 | 0.01 | Buy | 0.01 | $38.82 | $344,450 | SEC |
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2023 Q2 | 10,401 | <0.01 | Reduce 7.92% | <0.01 | $21.49 | $223,517 | SEC |
| 2023 Q1 | 11,296 | 0.01 | Add 5.17% | <0.01 | $23.99 | $270,991 | SEC |
| 2022 Q4 | 10,741 | 0.01 | Reduce 27.09% | <0.01 | $23.20 | $249,191 | SEC |
| 2022 Q3 | 14,732 | 0.01 | Buy | 0.01 | $16.02 | $236,000 | SEC |
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2021 Q2 | 33,751 | 0.01 | Buy | 0.01 | $23.64 | $798,000 | SEC |
| 2021 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2020 Q4 | 6,926 | <0.01 | Buy | <0.01 | $20.07 | $139,000 | SEC |
| 2019 Q2 | 0 | 0.00 | Sell 100.00% | 0.08 | SEC | ||
| 2019 Q1 | 395,080 | 0.08 | Buy | 0.08 | $15.14 | $5,982,000 | SEC |
| 2018 Q4 | 0 | 0.00 | Sell 100.00% | 0.08 | SEC | ||
| 2018 Q3 | 421,993 | 0.08 | Reduce 0.61% | <0.01 | $14.74 | $6,220,000 | SEC |
| 2018 Q2 | 424,590 | 0.12 | Buy | 0.12 | $23.85 | $10,126,000 | SEC |